StreetAlpha
Belite Bio, Inc · SEC Form 4

BLTE Insider Trading

From SEC Form 428 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Belite Bio, Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $41M sold.

← BLTE stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$41M28 sales · 5 insiders
Net−$41Mbought minus sold
Planned sales93%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMar2026-04: sold $4.9MApr2026-05: sold $723KMay2026-06: sold $2.9MJunJul2026-08: sold $132KAug2026-09: sold $31.9MSep2026-10: sold $83KOct2026-11: sold $332KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BLTE insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BLTE officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BLTE insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 12, 2026Hendrik Peter SchollChief Medical OfficerSale plan2,000$165.99$332K12,500Nov 16Form 4
Oct 1, 2026Hendrik Peter SchollChief Medical OfficerSale plan500$165.32$83K14,500Oct 5Form 4
Sep 8, 2026Hao-Yuan ChuangCFOSale plan67,395$189.98$12.8M26,038Sep 9Form 4
Sep 8, 2026Yu-Hsin LinCEOSale plan100,435$190.00$19.1M70,134Sep 9Form 4
Aug 12, 2026Yu-Hsin LinCEOSale plan365$180.35$66K170,569Aug 14Form 4
Aug 12, 2026Hao-Yuan ChuangCFOSale plan367$180.35$66K93,433Aug 14Form 4
Jun 18, 2026Hendrik Peter SchollChief Medical OfficerSale10,000$145.24$1.5M15,000Jun 22Form 4
Jun 16, 2026Hendrik Peter SchollChief Medical OfficerSale10,000$140.57$1.4M25,000Jun 17Form 4
May 7, 2026Nathan L. MataChief Scientific OfficerSale plan666$153.21$102K0May 8Form 4
May 6, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$153.84$154K666May 7Form 4
May 5, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$155.50$156K1,666May 6Form 4
May 4, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$155.64$156K2,666May 5Form 4
May 1, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$155.78$156K3,666May 4Form 4
Apr 30, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$156.97$157K4,666May 1Form 4
Apr 29, 2026Nathan L. MataChief Scientific OfficerSale plan1,000$155.82$156K5,666Apr 30Form 4
🔒 13 more trades. Create a free account or sign in to see them all.

BLTE insider trading FAQ

Are BLTE insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of BLTE on the open market in 0 trades, and 5 sold $41M in 28 trades, 93% of that under pre-arranged trading plans.

When did an BLTE insider last buy shares?

There has been no open market insider purchase of BLTE in the last two years.

When did an BLTE insider last sell shares?

Hendrik Peter Scholl (Chief Medical Officer) sold 2,000 shares for $332K on Nov 12, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice